Release Date: 10/02/17 12:27 Summary: Initial Director's Interest Notice Price Sensitive: No Download Document 62.69KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%